PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MATW vs. AXSM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


MATWAXSM
YTD Return-32.99%14.26%
1Y Return-38.36%21.95%
3Y Return (Ann)-8.36%45.39%
5Y Return (Ann)-3.81%27.24%
Sharpe Ratio-1.050.49
Daily Std Dev35.63%42.80%
Max Drawdown-75.27%-86.65%
Current Drawdown-62.64%-14.40%

Fundamentals


MATWAXSM
Market Cap$732.81M$4.44B
EPS$0.84-$6.58
PEG Ratio1.920.00
Total Revenue (TTM)$1.51B$291.49M
Gross Profit (TTM)$232.86M$259.54M
EBITDA (TTM)$145.21M-$320.72M

Correlation

-0.50.00.51.00.2

The correlation between MATW and AXSM is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

MATW vs. AXSM - Performance Comparison

In the year-to-date period, MATW achieves a -32.99% return, which is significantly lower than AXSM's 14.26% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%AprilMayJuneJulyAugustSeptember
-15.36%
18.30%
MATW
AXSM

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MATW vs. AXSM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Matthews International Corporation (MATW) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MATW
Sharpe ratio
The chart of Sharpe ratio for MATW, currently valued at -1.05, compared to the broader market-4.00-2.000.002.00-1.05
Sortino ratio
The chart of Sortino ratio for MATW, currently valued at -1.48, compared to the broader market-6.00-4.00-2.000.002.004.00-1.48
Omega ratio
The chart of Omega ratio for MATW, currently valued at 0.83, compared to the broader market0.501.001.500.83
Calmar ratio
The chart of Calmar ratio for MATW, currently valued at -0.58, compared to the broader market0.001.002.003.004.005.00-0.58
Martin ratio
The chart of Martin ratio for MATW, currently valued at -1.41, compared to the broader market-10.000.0010.0020.00-1.41
AXSM
Sharpe ratio
The chart of Sharpe ratio for AXSM, currently valued at 0.49, compared to the broader market-4.00-2.000.002.000.49
Sortino ratio
The chart of Sortino ratio for AXSM, currently valued at 0.97, compared to the broader market-6.00-4.00-2.000.002.004.000.97
Omega ratio
The chart of Omega ratio for AXSM, currently valued at 1.11, compared to the broader market0.501.001.501.12
Calmar ratio
The chart of Calmar ratio for AXSM, currently valued at 0.45, compared to the broader market0.001.002.003.004.005.000.45
Martin ratio
The chart of Martin ratio for AXSM, currently valued at 1.26, compared to the broader market-10.000.0010.0020.001.26

MATW vs. AXSM - Sharpe Ratio Comparison

The current MATW Sharpe Ratio is -1.05, which is lower than the AXSM Sharpe Ratio of 0.49. The chart below compares the 12-month rolling Sharpe Ratio of MATW and AXSM.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.50AprilMayJuneJulyAugustSeptember
-1.05
0.49
MATW
AXSM

Dividends

MATW vs. AXSM - Dividend Comparison

MATW's dividend yield for the trailing twelve months is around 4.01%, while AXSM has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
MATW
Matthews International Corporation
4.01%2.54%2.92%2.36%2.87%2.12%1.90%1.33%0.81%1.01%0.95%0.96%
AXSM
Axsome Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

MATW vs. AXSM - Drawdown Comparison

The maximum MATW drawdown since its inception was -75.27%, smaller than the maximum AXSM drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for MATW and AXSM. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%AprilMayJuneJulyAugustSeptember
-62.64%
-14.40%
MATW
AXSM

Volatility

MATW vs. AXSM - Volatility Comparison

The current volatility for Matthews International Corporation (MATW) is 7.78%, while Axsome Therapeutics, Inc. (AXSM) has a volatility of 9.77%. This indicates that MATW experiences smaller price fluctuations and is considered to be less risky than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%AprilMayJuneJulyAugustSeptember
7.78%
9.77%
MATW
AXSM

Financials

MATW vs. AXSM - Financials Comparison

This section allows you to compare key financial metrics between Matthews International Corporation and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items